The government has announced plans to seek advice on ketamine, including consideration of whether it should remain a Class B substance under the Misuse of Drugs Act 10971 or move to Class A, the most tightly regulated group. The BBC – among other media outlets – has covered this news at https://www.bbc.co.uk/news/articles/cp8306prgy6o
DSM Foundation Director, Founder and Dan’s mum Fiona Spargo-Mabbs said: “Ketamine is the most commonly mentioned substance by 15-18 year olds after those more widely available to young people – alcohol, nicotine in various forms and cannabis – when responding to the anonymous survey we send to students before we plan and deliver a drugs education workshop to them. Around one in five (18 per cent) named ketamine in response to the question ‘Which are the main substances people in your year group use, if they do?’ ahead of other substances such as nitrous oxide, cocaine or MDMA, and in some schools we work with this is significantly higher. This overall figure – gathered from over 2,100 young people in the autumn term – shows that ketamine is a drug that a significant number are aware of and feel is around for them and their peers, and so we welcome experts looking into it in depth.
“Our data shows how important it is that young people have access to relevant, up to date, and non-judgemental drug education about drugs, including ketamine, so they are able to develop the skills needed to navigate situations many of them find themselves in. It’s so important they’re able to make informed and empowered decisions, whether for themselves or to help their friends, as we want every young person to be able to get home safely, and to keep themselves safe from harm.”
The decision of the Policing Minister Dame Diana Johnson to request that the Advisory Council on the Misuse of Drugs (ACMD) make recommendations about ketamine stems from an increase in the prevalence of the drug in the UK in recent years. It was also prompted by concerns raised by Senior Coroner Alison Mutch following her investigation into the ketamine-related death of James Boland in October 2024; it appeared that the Class B drug ketamine had been chosen over Class A drugs because it was perceived as having less risk, with tragic consequences. In the year ending March 2024, in England and Wales nearly 270,000 people aged 16 to 59 years reported using it in the previous 12 months, putting them at risk of serious health problems including potentially irreversible damage to the bladder and kidneys.
Ketamine is also one of the drugs most commonly detected in spiking incidents, and it has been cited as an ingredient in “pink cocaine”, a dangerous cocktail of drugs that was recently in the headlines following its implication in the death of One Direction singer Liam Payne.
The DSM Foundation has a factsheet on ketamine for young people at https://www.dsmfoundation.org.uk/yp-factsheets/ and a Quick Guide for the adults in their lives (such as parents, caregivers and school staff) at https://www.dsmfoundation.org.uk/parents-resources/
